Bell John K 4
4 · DelMar Pharmaceuticals, Inc. · Filed Jan 2, 2020
Insider Transaction Report
Form 4
Bell John K
Director
Transactions
- Other
Common Stock
2019-12-31+29→ 9,759 total(indirect: Held by Onbelay Capital Inc.)
Holdings
- 35,000(indirect: Held by Registered Retirement Income Fund)
Common Stock
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.